miransertib
Showing 1 - 1 of 1
PIK3CA-Related Overgrowth Spectrum (PROS)/Proteus Syndrome Trial in Worldwide (Miransertib)
Terminated
- PIK3CA-Related Overgrowth Spectrum (PROS)/Proteus Syndrome
- Miransertib
-
Atlanta, Georgia
- +10 more
May 10, 2022